ARCHIVES

“Wild West” of Molecular Testing?: Caris Engaged in Aggressive Marketing, Improper Medicare Billing, Lawsuit Alleges

This article is from The Cancer Letter archive.

Vol. 40 No. 32 | August 8, 2014

Download PDF Visit The Full Archive

Related Articles

Report Criticizes NIH Grant Review

June 16, 1995

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

Reduced-Fat Diet May Cut Risk Of Breast Cancer Recurrence.

December 22, 2006

New Coalition To Lobby for Prevention

November 24, 1978

Physician Clinical Investigator Awards

April 15, 1983

NCI Offers 200 Cell Lines to Scientist

May 6, 1983